New routes to fight castrate-resistant prostate cancer: targeting α-methylacyl-CoA racemase (AMACR)

Guat Ling Lee, Maksims Jevglevskis, Timothy Woodman, Matthew Lloyd

Research output: Contribution to conference › Poster

Original languageEnglish
Publication statusUnpublished - 2015
EventSET for Britain - House of Commons, London, UK United Kingdom
Duration: 9 Mar 2015 → 9 Mar 2015

Exhibition

ExhibitionSET for Britain
CountryUK United Kingdom
CityLondon
Period9/03/15 → 9/03/15

Projects

AMACR Targeted Drugs for Treating Advance Prostate Cancer

Lloyd, M., James, T., Jevglevskis, M., Nathubhai, A., Threadgill, M. & Woodman, T.

Prostate Cancer UK

1/02/15 → 30/07/18

Project: UK charity

Targeting AMACR to Treat Castrate Resistant Prostate Cancer

Lloyd, M. & Woodman, T.

Prostate Cancer UK

5/10/11 → 31/01/15

Project: UK charity

Equipment

Avance III 500 NMR Spectrometer 500 MHz Nuclear Magnetic Resonance instrument (NMR) (9West)

Tim Woodman

Material and Chemical Characterisation (MC2)

Facility/equipment: Equipment

    • Cite this

    Lee, G. L., Jevglevskis, M., Woodman, T., & Lloyd, M. (2015). New routes to fight castrate-resistant prostate cancer: targeting α-methylacyl-CoA racemase (AMACR). Poster session presented at SET for Britain, London, UK United Kingdom.